L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-003957
Abstract: Background The repression or downregulation of programmed death-ligand 1 (PD-L1) can release its inhibition of T cells and activate antitumor immune responses. Although PD-1 and PD-L1 antibodies are promising treatments for diverse tumor types, their… read more here.
Keywords: hydroxytryptophan promotes; effect; promotes antitumor; htp ... See more keywords